Blue Horseshoe Stocks: Big Options Plays

Roku, Inc. ROKU 

We’re coming back for our recent extended-term ROKU calls once again this morning, as the stock’s performance yesterday provided the impetus for the addition of more big-time gains.

On the morning of September 23rd we targeted the ROKU 11/01 $115-118 Calls, after several pushes, we have now arrived at the following total possible gains in the three weeks since we alerted on these ideas.

$115 Calls – Range: 3.00-18.25 – Max Gain: 508%
$116 Calls – Range: 3.60-17.75 – Max Gain: 393%
$117 Calls – Range: 2.82-16.35 – Max Gain: 480%
$118 Calls – Range: 2.50-15.90 – Max Gain: 536%


More Options Review 

Yesterday we offered up a pair of fresh options trading ideas in the JNJ and UNH chains. Our shrewd calls, with the help of a majorly bullish session for the markets as a whole, provided us with the following opportunities in those calls that we highlighted. 

JNJ Weekly $130-132 Calls
$130 Calls – Range: 2.66-4.21 – Max Gain: 58%
$131 Calls – Range: 1.94-3.40 – Max Gain: 75%
$132 Calls – Range: 1.33-2.60 – Max Gain: 95%
____

UNH Weekly $222.50-225 Calls
$222.50 Calls – Range: 
9.00-17.20 – Max Gain: 91%
$225Calls – Range: 7.35-15.00 – Max Gain: 104%

____

More Fresh Ideas:
BAC Weekly $29.50-31 Calls
SNBR Weekly $47-49 Calls
UAL Weekly $89-90 Calls


Extended Watchlist:
VIVE, XBIO, AXSM, FTR, APDN, CTST, ALRN

Blue Horseshoe Stocks: SAGD Review & More

South American Gold Corp. SAGD
(soon to be Sativa Growth International)

On the morning of last Thursday the 21st, we signaled our interest in tracking SAGD, and at the time the stock was trading as low as .0135. In the week of trading which has followed, the stock has made a very nice move.

Yesterday, SAGD hit a new high of .0364 which represents a one-week upswing of 170% and continues our recent impressive trend of identifying not only hot options plays, but scoring big with stocks as well.

We should also mention that the company announced its plans to change its name and official focus to reflect the work it has been doing to move toward the cannabis space.(>>Read PR) It’s one of our favorite OTC market sectors, and we’ll be tracking SAGD as part of it moving forward.


Accenture plc. ACN – Recap

Speaking of success in options ideas, our fresh play from yesterday morning’s premarket report yielded fantastic single-session results. We designated the ACN Weekly $157.50-162.50 Calls as our go-to options play for the day and all three of the contracts contained in our highlighted range were big-time winners on the day.

$157.50 Calls – Range: 2.36-7.41 – Max Gain: 214%
$160 Calls – Range: 1.24-5.60 – Max Gain: 352%
$162.50 Calls – Range: .50-3.10 – Max Gain: 520%
_______

Fresh Options Ideas:
Nike Inc. – NKE Weekly $77-79 Calls
SPDRA S&P 500 ETF – SPY Weekly $270-272 Calls


Extended Watchlist:
IQ, BAC, VRTX, ACAD, DERM, PIR(bottom-watch)

Blue Horseshoe Stock: More Options Success

General Motors Co. GM

We went very options heavy in our report yesterday morning, updating our readers on the success of ideas we had earlier in the week, and also including a pair of fresh ideas, GM Weekly $40-42 Calls.

We’re pleased to report that all five of the contracts in our designated range produced the opportunity for tangible intraday profits.

$21 Calls – Range: 1.61-2.73 – Max Gain: 70%
$21.50 Calls – Range: 1.00-2.22 – Max Gain: 122%
$22 Calls – Range: .73-1.70 – Max Gain: 133%
$21.50 Calls – Range: .42-1.26 – Max Gain: 200%
$22 Calls – Range: .18-.85 – Max Gain: 372%

_____

Burlington Stores, Inc. BURL

Also freshly formulated in yesterday’s report was our idea for the BURL Weekly $141-144 Calls, and we were not disappointed on that front either. While the bottom half of the range was pushed too deep into the money for any serious activity, we quickly zeroed in on the top performers, the $143 and $144 Calls.

The $143’s managed a huge run from 1.45-5.80, marking an intraday surge of 300% while the $144‘s posted a range of 1.40-4.00, which works out to a 186% rip.


More Fresh Options Ideas

For the second day in a row we’ll present a fresh pair of options ideas, one longer-term and one for potential day trades today*:

Bank of America BAC 07/20 $29 & $30 Calls
Lululemon Athletica LULU Weekly $111-114 Calls

*Never trade weekly options on a Friday unless you an expert level trader with disposable funds


Extended Watchlist:
ATIS, HEAR, TOPS, SGLB, PETX, AMMA

Blue Horseshoe Stocks: Fresh Options Ideas & More

First we’d like to apologize for our email list members for the absence of yesterday’s premarket report. Our service provider was shut down for the most of the day rendering us unable to send our daily report via email. This is an exceedingly rare event, but in these cases, you can always bookmark and visit BlueHorseshoeStocks.com just before market open, as all of our newsletters are archived there for easy reference.

Alcobra Ltd. ADHD

We did include ADHD in yesterday’s report, but since many of readers happened to miss it, we’ll back up to the next most recent mention, when we alerted the stock on September 29th.

The stock did see sub-1.00 prices that day, but took a couple more sessions to see its low of .96. Since then ADHD has been on a steady run-up, culminating in a new high of 2.17, which represented a very nice 127% move in a three week period.


PayPal Holdings, Inc. PYPL

We want to highlight a range of options for PYPL after the company posted its quarterly earnings after market close yesterday. The stock has been on a nearly continual rise all year long, and in premarket trading today, PYPL shares have rocketed into blue skies, setting a new annual high with each uptick.

As we often do in these post-earnings beat gap-up situations, we’ll identify a set of options contracts in the PYPL chain to observe as things kick off this morning, in this case, the PYPL Weekly $71-72.50 Calls* for potential quick strike trades today.

*Important: Never trade options with a weekly expiration on a Friday unless you’re an expert trader with disposable funds. It’s extremely risky.



AcelRx Pharmaceuticals, Inc. ACRX

ACRX recently fell off a cliff after the FDA rejected the company’s NDA for its Dsuvia drug, however ACRX believes it can meet the accompanying guidelines to eventually submit a successful application. We did alert that event in last Friday’s report, and meanwhile, the stock is gapping up this morning after having seen and bounced off of new annual lows yesterday. 

Recovering even a fraction of the ground it lost last week, could spell significant upswings for ACRX in coming sessions.


Extended Watchlist:
 AUPH, GALT, HMNY, INFI, ONVO, NEOT, BAC,

Blue Horseshoe Stocks: BVTK Pops Again & More

Bravatek Solutions, Inc. BVTK

BVTK was among our mentions in Wednesday’s premarket report after it was unearthed in our chatroom* the previous morning before making a 500% move.  Those who missed that run got another chance right away as the stock ran from .0009-.0035 that afternoon, and topped out at .0041 to close out the short week on Friday. That added another two-day swing of 355% to the activity we had observed in BVTK, which was followed by a pullback to .0015.

Once again, to kick off the new trading week yesterday, BVTK began to run, returning to a high of .0034 on the day, representing yet another two-day upswing out of this volatile runner amounting to 127%  The stock ended the session having traded roughly three-and-a-half times its monthly average volume. Things could get very interesting if it can manage to crack resistance at the previous swing high of .0041.

The company filed an 8-K this morning as well , pertaining to an agreement with i3 Integrative Creative Solutions, pursuant to which i3 Integrative will promote and solicit commitments in the United States federal government military and civilian markets regarding the Company’s cybersecurity email software and telecom services. (>>View Filing)

*We encourage all of our readers to join in on our daily in-session live chats. To participate, simply create/sign into your Skype account and send a contact request to ‘stocksumo’.



Bank of America Corp BAC – Options Ideas 

Whenever we spot an opportunity to swoop in post-earnings with some options ideas, we jump on it right away, and that’s what we have with BAC this morning.

We haven’t highlighted this stock in quite awhile,but with a very solid beat on earnings and a small gap-up in the premarket, we’re going to want to signal a couple of short term contracts for observation in the BAC Weekly $22.50 and $23 Calls.

In the event that a more sustained rebound is in the cards, considering the fact that BAC was already coming off of a relative bottom just yesterday, we’ll have the BAC 05/12 $23.50 & $24 Calls on watch as well.



Bottom-Watchlist

We want to put an observational tag on both Sorrento Therapeutics, Inc. SRNE and OncoMed Pharmaceuticals, Inc. OMED.  Both of these stocks have taken serious beatings of late, and consequently, are in extreme oversold territory. Chances for recovery plays here seem quite high, so we’re going to watch for these to establish higher lows in sessions ahead.


Extended Watchlist:
JAMN, MYDX, CAB, SSYS, BIOC, NFLX

Get Our FREE Daily Reports!